Steigerwald, Gordon & Koch Inc.
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1731876
LEESBURG, VA
Position in TMO
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$203,493
-$473 QoQ
Shares Held
414
+17.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Steigerwald, Gordon & Koch Inc. holds $13,749,217 across 13 Diagnostics & Research names. TMO ranks #4 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVTY |
Revvity, Inc.
|
108,474 | $9,503,407 | |
| 2 | DHR |
Danaher Corp /De/
|
15,971 | $3,028,101 | |
| 3 | RDNT |
RadNet, Inc.
|
10,665 | $596,066 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
This page
|
414 | $203,493 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
200 | $112,378 | |
| 6 | A |
Agilent Technologies, Inc.
|
667 | $76,024 | |
| 7 | LH |
Labcorp Holdings Inc.
|
259 | $69,103 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
350 | $59,689 |
All Filings in TMO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $203,493 | 414 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $203,966 | 352 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $178,487 | 368 | Shares | Sole | 2025-10-23 | |
| 2024-09-30 | $210,313 | 340 | Shares | Sole | 2024-10-09 | |
| 2023-03-31 | $201,729 | 350 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $203,755 | 370 | Shares | Sole | 2023-01-17 | |
| 2021-12-31 | $234,201 | 351 | Shares | Sole | 2022-01-26 | |
| No filing history on record for this holder in this stock. | ||||||